Interaction of Mitochondrial Calcium and ROS in Neurodegeneration

  • Artyom Y. Baev
    Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent 100174, Uzbekistan
  • Andrey Y. Vinokurov
    Cell Physiology and Pathology Laboratory, Orel State University, 302026 Orel, Russia
  • Irina N. Novikova
    Cell Physiology and Pathology Laboratory, Orel State University, 302026 Orel, Russia
  • Viktor V. Dremin
    Cell Physiology and Pathology Laboratory, Orel State University, 302026 Orel, Russia
  • Elena V. Potapova
    Cell Physiology and Pathology Laboratory, Orel State University, 302026 Orel, Russia
  • Andrey Y. Abramov
    Cell Physiology and Pathology Laboratory, Orel State University, 302026 Orel, Russia

説明

<jats:p>Neurodegenerative disorders are currently incurable devastating diseases which are characterized by the slow and progressive loss of neurons in specific brain regions. Progress in the investigation of the mechanisms of these disorders helped to identify a number of genes associated with familial forms of these diseases and a number of toxins and risk factors which trigger sporadic and toxic forms of these diseases. Recently, some similarities in the mechanisms of neurodegenerative diseases were identified, including the involvement of mitochondria, oxidative stress, and the abnormality of Ca2+ signaling in neurons and astrocytes. Thus, mitochondria produce reactive oxygen species during metabolism which play a further role in redox signaling, but this may also act as an additional trigger for abnormal mitochondrial calcium handling, resulting in mitochondrial calcium overload. Combinations of these factors can be the trigger of neuronal cell death in some pathologies. Here, we review the latest literature on the crosstalk of reactive oxygen species and Ca2+ in brain mitochondria in physiology and beyond, considering how changes in mitochondrial metabolism or redox signaling can convert this interaction into a pathological event.</jats:p>

収録刊行物

  • Cells

    Cells 11 (4), 706-, 2022-02-17

    MDPI AG

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ